Article Information
History
- February 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alana Gerhardt1,*,†,
- Emily Voigt2,*,†,
- Michelle Archer1,
- Sierra Reed1,
- Elise Larson3,
- Neal Van Hoeven2,
- Ryan Kramer1,
- Christopher Fox3 and
- Corey Casper1,2,3,4,5
- 1Product Development Group, Infectious Disease Research Institute, Seattle, WA, USA.
- 2RNA Vaccines Group, Infectious Disease Research Institute, Seattle, WA, USA.
- 3Formulation Sciences Group, Infectious Disease Research Institute, Seattle, WA, USA.
- 4Departments of Medicine and Global Health, University of Washington, Seattle, WA, USA.
- 5Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- ↵*Corresponding authors. Email: alana.gerhardt{at}idri.org; emily.voigt{at}idri.org
↵† These authors contributed equally to this work.